During the projected period, it is anticipated that rising cancer rates will fuel the expansion of the worldwide ambulatory infusion centre market. For instance, according to Our World in Data, a group specialising in research and data on the biggest health issues in the world, an estimated 9.6 million people worldwide died from various cancers in 2017, and every sixth death worldwide that year was attributed to cancer.
The market for Ambulatory Infusion Centres is anticipated to reach a value of US$ 47,013.5 million in 2020 and grow at a CAGR of 9.0% from 2020 to 2027.
Leading Companies in the Ambulatory Infusion Center Industry:
Option Care Health:
1. created in 1979. Infusion services are offered at homes and other locations by Option Care Health Inc. It offers treatment for a variety of conditions, including chronic inflammatory diseases, neurological illnesses, heart failure, and bleeding disorders. United States headquarters. Option Care Health will pay $3.6 billion to acquire the home health and hospice company Amedisys.
PharmaScript:
2. Long-term care and post-acute care facilities are the target market for this provider of pharmacy services. To support healthcare facilities in providing patient-centered, efficient, and effective treatment, the organisation provides quality assurance, cost containment, and innovative technology services. created in 2009. United States headquarters. With the acquisition of Doehring's LTC Pharmacy, PharmScript expands into Illinois.
Cleveland Clinic:
3. Publisher of books on medicine. The business publishes books on a variety of subjects, including arthritis, heart attacks, women's health, ageing, cancer, and diabetes, infertility, and health literacy. These books aim to refute common misconceptions about medicine, health care, and medical treatment. created in 2005. United States headquarters. Sisters of Charity and Cleveland Clinic agree to purchase Mercy Medical Centre.
